Press releaseNewsfile
Azenta
AZTA · NASDAQ
$35.73+$0.89 (+2.55%)TodayMarket closed ·
Prev close $34.84
Latest news
- Press releaseNewsfile
ROSEN, NATIONALLY REGARDED INVESTOR RIGHTS COUNSEL, Encourages Azenta, Inc. Investors to Inquire About Securities Class Action Investigation - AZTA
- Press releaseNewsfile
ROSEN, TOP-RANKED TRIAL ATTORNEYS, Encourages Azenta, Inc. Investors to Inquire About Securities Class Action Investigation - AZTA
- Press releaseNewsfile
ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Azenta, Inc. Investors to Inquire About Securities Class Action Investigation - AZTA
- Press releaseNewsfile
ROSEN, SKILLED INVESTOR COUNSEL, Encourages Azenta, Inc. Investors to Inquire About Securities Class Action Investigation - AZTA
- Press releaseNewsfile
ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Azenta, Inc. Investors to Inquire About Securities Class Action Investigation - AZTA
- Press releaseNewsfile
ROSEN, A LEADING NATIONAL FIRM, Encourages Azenta, Inc. Investors to Inquire About Securities Class Action Investigation - AZTA
- Press releaseNewsfile
ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Azenta, Inc. Investors to Inquire About Securities Class Action Investigation - AZTA
- Press releaseNewsfile
ROSEN, A LEADING LAW FIRM, Encourages Azenta, Inc. Investors to Inquire About Securities Class Action Investigation - AZTA
- NewsAvi Kapoor
Apogee Enterprises Posts Upbeat Q2 Earnings, Joins Constellation Energy, Freshworks And Other Big Stocks Moving Higher On Tuesday
- Press releaseNewsfile
ROSEN, NATIONAL INVESTOR COUNSEL, Encourages Azenta, Inc. Investors to Inquire About Securities Class Action Investigation - AZTA
- Press releaseNewsfile
ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Azenta, Inc. Investors to Inquire About Securities Class Action Investigation - AZTA
- Press releaseNewsfile
ROSEN, SKILLED INVESTOR COUNSEL, Encourages Azenta, Inc. Investors to Inquire About Securities Class Action Investigation - AZTA
- Press releaseGlobe Newswire
Azenta, Inc. Investor News: If You Have Suffered Losses in Azenta, Inc., You Are Encouraged to Contact The Rosen Law Firm About Your Rights
- Press releaseBusiness Wire
Rosen Law Firm Encourages Azenta, Inc. Investors to Inquire About Securities Class Action Investigation - AZTA
- Press releasePRNewswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Azenta, Inc. - AZTA
- Press releaseGlobe Newswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Azenta, Inc. - AZTA
- Press releasePRNewswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Azenta, Inc. - AZTA
- Press releasePRNewswire
Azenta Receives Full Repayment of $35 Million Vendor Loan Related to Sale of B Medical Systems
- Press releaseGlobe Newswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Azenta, Inc. - AZTA
- Press releasePRNewswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Azenta, Inc. - AZTA
- Press releaseGlobe Newswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Azenta, Inc. - AZTA
- NewsAvi Kapoor
Crude Oil Down 3%; XPeng Shares Fall After Q2 Results
- Press releasePRNewswire
AZENTA ANNOUNCES LEADERSHIP TRANSITION
- News
Azenta Q3 Adj. EPS $0.16 Beats $0.11 Estimate, Sales $161.000M Beat $149.288M Estimate
- Press releasePRNewswire
Azenta Reports Third Quarter Results for Fiscal 2026, Ended June 30, 2026.
- Press releaseGlobe Newswire
Cabot Corporation Announces Planned Leadership Transition
- Press releasePRNewswire
Azenta Announces Fiscal 2026 Third Quarter Conference Call and Webcast
- Press releasePRNewswire
Azenta Completes Sale of B Medical Systems
- Press releasePRNewswire
Azenta, Inc. (AZTA) Securities Fraud Investigation - Levi & Korsinsky
- Press releasePRNewswire
Azenta Publishes 2025 Environmental, Social, and Governance (ESG) Report
- Press releaseGlobe Newswire
Levi & Korsinsky Announces Investigation of Securities Claims Against Azenta, Inc. (AZTA)
- Press releaseGlobe Newswire
AZTA Investors Have Opportunity to Join Azenta, Inc. Fraud Investigation with the Schall Law Firm
- Press releaseGlobe Newswire
INVESTOR ALERT: Investigation of Azenta, Inc. (AZTA) announced by Holzer & Holzer, LLC
- Press releaseGlobe Newswire
AZTA SHAREHOLDER INVESTIGATION: Levi & Korsinsky Investigates Azenta, Inc. for Possible Securities Law Violations
- News
12 Health Care Stocks Moving In Wednesday's Intraday Session
- Press releasePRNewswire
Azenta Reports Second Quarter Results for Fiscal 2026, Ended March 31, 2026, Updates Full Year Fiscal 2026 Guidance, and Extends Long-Range Plan to 2029
- NewsTanya Rawat
Azenta (AZTA) Stock Drops 13% After-Hours — What's Happening?
- News
12 Health Care Stocks Moving In Wednesday's After-Market Session
- Press releasePRNewswire
Azenta Completes Strategic Acquisition of UK Biocentre Limited, to Expand Biorepository Capabilities
- News
Where Azenta Stands With Analysts
- Press releasePRNewswire
Azenta Authorizes $250 Million Share Repurchase Program
- NewsAvi Kapoor
Ross Stores Posts Strong Q3 Results, Joins Enviri, Azenta And Other Big Stocks Moving Higher On Friday
- Press releasePRNewswire
Fresenius Medical Care's Third-Party Clinical Research Organization Frenova Announces Strategic Collaboration Advancing Genomics-Driven, Precision Kidney Disease Care
- News
Azenta Obtains Regulatory Approval For Clinical Long-Read Whole Genome Sequencing Test
- Press releasePRNewswire
Azenta Obtains Regulatory Approval for Clinical Long-Read Whole Genome Sequencing Test
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.